197 related articles for article (PubMed ID: 36803572)
1. Drug discovery for parasitic diseases: powered by technology, enabled by pharmacology, informed by clinical science.
Rao SPS; Manjunatha UH; Mikolajczak S; Ashigbie PG; Diagana TT
Trends Parasitol; 2023 Apr; 39(4):260-271. PubMed ID: 36803572
[TBL] [Abstract][Full Text] [Related]
2. Expanding Bromodomain Targeting into Neglected Parasitic Diseases.
Tallant C; Bamborough P; Chung CW; Gamo FJ; Kirkpatrick R; Larminie C; Martín J; Prinjha R; Rioja I; Simola DF; Gabarró R; Calderón F
ACS Infect Dis; 2021 Nov; 7(11):2953-2958. PubMed ID: 34612618
[TBL] [Abstract][Full Text] [Related]
3. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
Previti S; Di Chio C; Ettari R; Zappalà M
Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and challenges in antiparasitic drug discovery.
Pink R; Hudson A; Mouriès MA; Bendig M
Nat Rev Drug Discov; 2005 Sep; 4(9):727-40. PubMed ID: 16138106
[TBL] [Abstract][Full Text] [Related]
5. Parasitic infections.
Am J Transplant; 2004 Nov; 4 Suppl 10():142-55. PubMed ID: 15504227
[No Abstract] [Full Text] [Related]
6. Developing drugs for parasitic diseases.
Andreopoulos S
Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858
[No Abstract] [Full Text] [Related]
7. Antiparasitic therapy in children.
Moon TD; Oberhelman RA
Pediatr Clin North Am; 2005 Jun; 52(3):917-48, viii. PubMed ID: 15925668
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
9. Honoring antiparasitics: The 2015 Nobel Prize in Physiology or Medicine.
Chen WJ
Biomed J; 2016 Apr; 39(2):93-7. PubMed ID: 27372164
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery.
Jain V; Sharma A; Singh G; Yogavel M; Sharma A
ACS Infect Dis; 2017 Apr; 3(4):281-292. PubMed ID: 28195698
[TBL] [Abstract][Full Text] [Related]
11. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
Al Jalali V; Zeitlinger M
Clin Pharmacokinet; 2020 Jul; 59(7):827-847. PubMed ID: 32100246
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of parasitic diseases: current status and new advance].
Lin Y; Xu Z
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(1):68-72. PubMed ID: 12078213
[No Abstract] [Full Text] [Related]
13. [Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases].
Pérez JL; Carranza C; Mateos F
Rev Esp Quimioter; 2009 Jun; 22(2):93-105. PubMed ID: 19544101
[TBL] [Abstract][Full Text] [Related]
14. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
Sánchez-Delgado RA; Anzellotti A
Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440
[TBL] [Abstract][Full Text] [Related]
15. New strategies and paradigm for drug target discovery: a special focus on infectious diseases tuberculosis, malaria, leishmaniasis, trypanosomiasis and gastritis.
Neelapu NR; Srimath-Tirumala-Peddinti RC; Nammi D; Pasupuleti AC
Infect Disord Drug Targets; 2013 Oct; 13(5):352-64. PubMed ID: 24712675
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
[TBL] [Abstract][Full Text] [Related]
17. Critical challenges and emerging paradigms in drug discovery.
Whitty A; Gelb MH
Curr Opin Chem Biol; 2010 Aug; 14(4):437-9. PubMed ID: 20621548
[No Abstract] [Full Text] [Related]
18. Harnessing the 12 Green Chemistry Principles for Sustainable Antiparasitic Drugs: Toward the One Health Approach.
Martinengo B; Diamanti E; Uliassi E; Bolognesi ML
ACS Infect Dis; 2024 Jun; 10(6):1856-1870. PubMed ID: 38724015
[TBL] [Abstract][Full Text] [Related]
19. Current antiparasitic drug targets and a paradigm shift in discovery of new antiparasitic drugs and vaccines.
Tekwani BL
Curr Drug Targets; 2008 Nov; 9(11):921. PubMed ID: 18991603
[No Abstract] [Full Text] [Related]
20. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
Date AA; Joshi MD; Patravale VB
Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
